Merck Wants 3rd Circ. Rethink On Fosamax Warning Claims
Merck asked the Third Circuit on Wednesday to reconsider its revival of claims in multidistrict litigation that the drugmaker failed to warn patients about the risk of irregular hip fractures from...To view the full article, register now.
Already a subscriber? Click here to view full article